Skip to main content
See every side of every news story
Published loading...Updated

EU Approves New Twice-Yearly Jabi to Prevent HIV

Summary by Euronews
The new treatment option comes amid a rise in HIV cases in parts of Europe.

5 Articles

Lean Left

The European Commission granted a marketing authorisation valid for the bilateral medicinal product of Gilead Sciences for HIV infection, announced to the company according to Reuters. The medicinal product, known as lenacapavir's scientific name, will be marketed...

·Romania
Read Full Article

Following the decision of the European Commission, an AIDS vaccine, which is administered twice a year, will become available in the European Union. It blocks the reproduction of the human immunodeficiency virus in the body and reduces the risk of infection. In clinical trials, the drug has shown 100 percent effectiveness, experts say, this is the biggest medical breakthrough of 2024. If vaccinated twice a year, daily pills will no longer be nee…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Business Wire broke the news in Crystal River, United States on Tuesday, August 26, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal